{
  "name":"CPAM0046",
  "description":": LMNA-related congenital muscular dystropy",
  "nominated_by":"Dr. Person Two",
  "genomic_units":[
     {
        "gene":"LMNA",
        "transcripts":[
           {
              "transcript":"NM_170707.3"
           }
        ],
        "variants":[
           {
              "hgvs_variant":"NM_170707.3:c.745C>T",
              "c_dot":"c.745C>T",
              "p_dot":"p.R249W",
              "build":"hg19",
              "case":[
                 {
                    "field":"Evidence",
                    "value":[
                       "PS2",
                       "PS3",
                       "PM2",
                       "PP3",
                       "PP5"
                    ]
                 },
                 {
                    "field":"Interpretation",
                    "value":[
                       "Pathogenic"
                    ]
                 },
                 {
                    "field":"Inheritance",
                    "value":[
                       "De Novo"
                    ]
                 }
              ]
           }
        ]
     }
  ],
  "sections":[
     {
        "header":"Brief",
        "content":[
           {
              "type":"section-text",
              "field":"Nominator",
              "value":[
                 "Dr. Person Two (Local) - working with Dr. Person Three in Person Four Lab"
              ]
           },
           {
              "type":"section-text",
              "field":"Participant",
              "value":[
                 "Male, YOB: 2019"
              ]
           },
           {
              "type":"section-text",
              "field":"Phenotype",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"ACMG Classification",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"ACMG Classification Criteria",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"ACMG Criteria To Add",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"Decision",
              "value":[
                 
              ]
           }
        ]
     },
     {
        "header":"Clinical History",
        "content":[
           {
              "type":"section-text",
              "field":"Clinical Diagnosis",
              "value":[
                 "LMNA-related congenital muscular dystropy"
              ]
           },
           {
              "type":"section-text",
              "field":"Affected Individuals Identified",
              "value":[
                 "Male, YOB: 2019"
              ]
           },
           {
              "type":"section-text",
              "field":"Sequencing",
              "value":[
                 "WES"
              ]
           },
           {
              "type":"section-text",
              "field":"Testing",
              "value":[
                 "WES - February  2020;"
              ]
           },
           {
              "type":"section-text",
              "field":"Systems",
              "value":[
                 "Growth Parameters; Craniofacial; Musculoskeletal; Gastrointestinal; Behavior, Cognition and Development; Neurological"
              ]
           },
           {
              "type":"section-text",
              "field":"Additional Details",
              "value":[
                 "Review of VUSes (Why not considered)",
                 "NEB (NM_001164508.1)  | c.7385C>G (p.A2462G) (Pat.) and c.16625A>G (p.H5542R) (Mat.).",
                 " - Associated with Nemaline myopathy 2, autosomal recessive",
                 " - Both variants  are still classified as VUS (last evaluated Feb 2020)",
                 " - 195 out of 203 (96.1%) non-VUS missense variants in gene NEB are benign",
                 " ",
                 "LYZL6 (NM_020426.2)  | c.228G>C (p.Q76H) (Mat./Pat.)",
                 " - Lysozyme Like 6.",
                 " - No currently known disease associations.",
                 " ",
                 "NOL6 (NM_022917.4)  | c.518G>A (p.R173Q) (Pat.) and c.91G>A (p.G31R) (Mat.).",
                 " - Nucleolar protein 6.",
                 " - No currently known disease associations"
              ]
           }
        ]
     },
     {
        "header":"Pedigree",
        "attachment_field":"Pedigree",
        "content":[
           {
              "type":"images-dataset",
              "field":"Pedigree",
              "value":[
                 
              ]
           }
        ]
     },
     {
        "header":"LMNA Gene To Phenotype",
        "attachment_field":"LMNA Gene To Phenotype",
        "content":[
           {
              "type":"images-dataset",
              "field":"LMNA Gene To Phenotype",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"HPO Terms",
              "value":[
                 "HP:0001508:Failure to thrive; HP:0001357:Plagiocephaly; HP:0000473:Torticollis; HP:0003560:Muscular dystrophy; HP:0003701:Proximal muscle weakness; HP:0009062:Infantile axial hypotonia; HP:0012389:Appendicular hypotonia; HP: 0003236:Elevated serum creatine kinase; HP:0002020:Gastroesophageal reflux; HP:0011471:Gastrostomy tube feeding in infancy; HP:0011968:Feeding difficulties; HP:0001263:Global developmental delay; HP:0001265:Hyproflexia; HP:0032988:Persistent head lag; HP:0000960:Sacral dimple;"
              ]
           }
        ]
     },
     {
        "header":"LMNA Molecular Mechanism",
        "content":[
           {
              "type":"section-text",
              "field":"Function Overview",
              "value":[
                 
              ]
           }
        ]
     },
     {
        "header":"LMNA Function",
        "attachment_field":"LMNA Function",
        "content":[
           {
              "type":"images-dataset",
              "field":"LMNA Function",
              "value":[
                 
              ]
           }
        ]
     },
     {
        "header":"Model Goals",
        "content":[
           {
              "type":"section-text",
              "field":"Model of Interest",
              "value":[
                 "Zebrafish"
              ]
           },
           {
              "type":"section-text",
              "field":"Goals",
              "value":[
                 "Functional impact confirmation (animal/cell modeling)",
                 "Therapeutic predictions (in-silico predictions)",
                 "Downstream applications (sharing model to conduct larger drug screens)"
              ]
           },
           {
              "type":"section-text",
              "field":"Proposed Model/Project",
              "value":[
                 "Contribute a dominant negative patient-variant model to the existing zebrafish model (LOF; in-progress)",
                 "Will be used in NBL 240: a research-based undergraduate course at UAB"
              ]
           },
           {
              "type":"section-text",
              "field":"Existing Collaborations",
              "value":[
                 
              ]
           },
           {
              "type":"section-text",
              "field":"Existing Funding",
              "value":[
                 
              ]
           }
        ]
     }
  ],
  "timeline":[
     {
        "event":"create",
        "timestamp":"2022-10-09T21:13:22.687000",
        "username":"vrr-prep"
     },
     {
        "event":"ready",
        "timestamp":"2022-10-09T21:14:22.687000",
        "username":"vrr-prep"
     },
     {
        "event":"opened",
        "timestamp":"2022-10-09T21:15:22.687000",
        "username":"vrr-prep"
     },
     {
        "event":"approve",
        "timestamp":"2022-10-09T21:16:22.687000",
        "username":"vrr-prep"
     }
  ]
}